newsfilter
← Latest News
U.S. Department of Energy·

DOE’s Office of Energy Dominance Financing Announces Conditional Commitment for a Domestic Medical Isotope Manufacturing Facility

  • The U.S. Department of Energy's Office of Energy Dominance Financing issued a conditional commitment for a $263 million loan to SHINE Chrysalis, LLC for a medical isotope facility in Janesville, Wisconsin.
  • The facility will produce molybdenum-99 using fusion & fission technology, creating the only domestic commercial supply of the isotope used in over 40,000 daily U.S. medical procedures.
  • The project aims to end reliance on foreign imports of medical isotopes, thereby enhancing national security & reducing costs for American patients.
  • EDF Director Gregory A. Beard stated the loan supports President Trump's policy to onshore critical production & strengthen the next-generation nuclear workforce.
  • SHINE's technology was developed over 16 years with funding from the National Nuclear Security Administration & support from national laboratories.
  • NNSA Deputy Administrator Dr. Matthew Napoli noted the facility is 75% complete & the loan will finalize the project to ensure reliable access to American-made isotopes.
  • EDF emphasizes financing projects that advance U.S. energy security, grid reliability, & lower costs while empowering the private sector.
  • The loan remains conditional until DOE & SHINE satisfy specific technical, legal, environmental, & financial requirements before definitive funding.